XML 123 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - (Tables)
12 Months Ended
Dec. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Number and Weighted Average Exercise Price of Options Issued and Outstanding under All Stock Option Plans
The number and weighted-average exercise price of options issued and outstanding under all of the Company’s equity plans are as follows:
Year Ended
December 30,
2023
Year Ended
December 31,
2022
Year Ended
January 1,
2022
(in millions, except for weighted-average exercise prices)SharesWeighted-Average
Exercise
Price
SharesWeighted-Average
Exercise
Price
SharesWeighted-Average
Exercise
Price
Options outstanding, beginning of period2.8 $83.85 2.9 $81.38 3.4 $77.44 
Granted0.1 177.29 0.1 150.91 0.1 250.15 
Canceled— 45.96 (0.1)162.77 (0.2)149.11 
Exercised(0.2)43.22 (0.1)54.53 (0.4)53.55 
Options outstanding, end of period2.7 $87.79 2.8 $83.85 2.9 $81.38 
Options exercisable, end of period2.4 $73.79 2.4 $65.83 2.2 $57.09 
Number and Weighted Average Exercise Price of Outstanding and Exercisable Options
The number and weighted-average exercise price of outstanding and exercisable stock options segregated by exercise price ranges were as follows:
Year Ended
December 30,
2023
Year Ended
December 31,
2022
(in millions, except range of exercise prices and average remaining contractual life)
Options OutstandingOptions
Exercisable
Options OutstandingOptions
Exercisable
Range of Exercise PricesNumber of
Options
Average
Remaining
Contractual
Life
Number of
Options
Number of
Options
Average
Remaining
Contractual
Life
Number of
Options
$15.00 to $50.00
1.2 1.51.2 1.3 2.41.3 
$50.01 to $80.00
— 2.5— 0.1 3.70.1 
$80.01 to $120.00
0.7 3.70.7 0.8 4.80.7 
$120.01 to $160.00
0.4 6.00.3 0.4 7.10.2 
$160.01 to $200.00
0.3 7.00.1 0.2 7.20.1 
$200.01 to $230.00
— 6.5— — 7.2— 
$230.01 to $280.00
0.1 7.00.1 — 8.0— 
Total
2.7 4.92.4 2.8 4.32.4 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The number of RSUs issued and outstanding under all of the Company’s equity plans are as follows:
Year Ended
December 30,
2023
Year Ended
December 31,
2022
Year Ended
January 1,
2022
(in millions, except for weighted-average grant date fair value)
UnitsWeighted-Average
Grant Date
Fair Value
UnitsWeighted-Average
Grant Date
Fair Value
UnitsWeighted-Average
Grant Date
Fair Value
RSUs outstanding, beginning of period3.2 $105.65 3.0 $104.13 2.9 $99.66 
Granted
0.5 125.44 0.3 148.52 0.1 257.43 
Canceled(0.1)172.19 (0.1)168.90 — 204.33 
Vested(0.1)173.18 — 184.04 — 163.71 
RSUs outstanding, end of period3.5 $105.87 3.2 $105.65 3.0 $104.13 
Schedule of Nonvested Performance-based Units Activity
The number of PSUs outstanding under all of the Company’s equity plans are as follows:
Year Ended
December 30,
2023
Year Ended
December 31,
2022
Year Ended
January 1,
2022
(in millions, except for weighted-average grant date fair value)
UnitsWeighted-Average
Grant Date
Fair Value
UnitsWeighted-Average
Grant Date
Fair Value
UnitsWeighted-Average
Grant Date
Fair Value
PSUs outstanding, beginning of period0.3 $180.04 0.3 $168.68 0.4 $120.28 
Granted(1)
0.1 
(1)
204.67 0.3 
(1)
145.49 0.2 250.73 
Canceled— 155.98 (0.1)139.73 — 166.84 
Vested(0.1)179.42 (0.2)127.46 (0.3)86.95 
PSUs outstanding, end of period0.3 $190.04 0.3 $180.04 0.3 $168.68 
(1) On February 27, 2023, the Audit Committee approved the weighted payout percentage for the 2019 PSU awards (three-year performance period), which were based upon the Company’s actual fiscal year 2022 performance against pre-established performance objectives. Included in the granted amount are those additional PSUs earned based on actual performance achieved. These PSUs were originally awarded at target.
Range of Assumptions Used and Resulting Weighted-Average Fair Value of Options Granted at Date of Grant The range of assumptions used and the resulting weighted-average fair value of options granted at the date of grant were as follows:
Year Ended
December 30,
2023
Year Ended
December 31,
2022
Year Ended
January 1,
2022
Risk-free interest rate
3.6% to 4.2%
1.0% to 1.9%
0.3% to 0.9%
Expected term (in years)
5.1 years to 5.9 years
5.1 years to 5.7 years
5.1 years to 5.6 years
Estimated volatility
31.6% to 36.7%
31.2% to 38.9%
30.9% to 34.7%
Expected dividends0%0%0%
Weighted-average fair value of options granted$75.08 per share$49.69 per share$75.72 per share
Share-Based Compensation Expense Included in Consolidated Statements of Operations
The following table presents the total stock-based compensation expense that is included in each functional line item of the consolidated statements of operations:
(in millions)
Year Ended
December 30,
2023
Year Ended
December 31,
2022
Year Ended
January 1,
2022
Cost of goods sold$1.1 $1.0 $0.8 
Selling, general and administrative(1.5)32.9 31.3 
Research and development7.4 13.8 12.5 
Total
$7.0 $47.7 $44.6